Am J Perinatol
DOI: 10.1055/a-2097-1852
Original Article

Maternal–Fetal Results of COVID-19-Infected Pregnant Women Treated with Extracorporeal Membrane Oxygenation: A Descriptive Report

Jorge Luis Alvarado-Socarras
1   Department of Pediatrics, Fundación Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Doris C. Quintero-Lesmes
2   Research Center, Investigation Center, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Delia Theurel Martin
3   Department of Pediatric-Neonatal Critical Care, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Raul Vasquez
4   Department of Critical Care Medicine, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Mary Mendoza Monsalve
5   ECMO Department, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Lizeth Mogollon Cristancho
4   Department of Critical Care Medicine, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Leonardo Salazar Rojas
5   ECMO Department, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Jenifer Leon Martinez
6   Department of Radiology, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Carlos Riaño Medina
7   Department of Perinatal Medicine, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
,
Camilo Pizarro Gomez
4   Department of Critical Care Medicine, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
› Author Affiliations
Funding None.

Abstract

Objective COVID-19 infection may produce severe pneumonia, mainly in the adult population. Pregnant women with severe pneumonia are at high risk of developing complications, and conventional therapy sometimes fails to reverse hypoxemia. Therefore, extracorporeal membrane oxygenation (ECMO) is an option in cases with refractory hypoxemic respiratory failure. This study aims to evaluate the maternal–fetal risk factors, clinical characteristics, complications, and outcomes of 11 pregnant or peripartum patients with COVID-19 treated with ECMO.

Study Design This is a retrospective descriptive study of 11 pregnant women undergoing ECMO therapy during the COVID-19 pandemic.

Results In our cohort, four patients underwent ECMO during pregnancy (36.3%) and 7 during the postpartum period. Initially, they started on venovenous ECMO, and three patients were required to change modality due to clinical conditions. In total, 4/11 pregnant women (36.3%) died. We established two periods that differed in the implementation of a standardized care model for reducing associated morbidities and mortality. Neurological complications were responsible for most deaths. Regarding fetal outcomes at early-stage pregnancies on ECMO (4), we report three stillbirths (75%), and one newborn (twin pregnancy) survived and had a favorable evolution.

Conclusion At later-stage pregnancies, all newborns survived, and we did not identify any vertical infection. ECMO therapy is an alternative for pregnant women with severe hypoxemic respiratory failure due to COVID-19, and may improve maternal and neonatal results. Regarding fetal outcomes, the gestational age played a definitive role. However, the main complications reported in our series and others are neurological. It is essential to develop novel, future interventions to prevent these complications.



Publication History

Received: 22 November 2022

Accepted: 19 May 2023

Accepted Manuscript online:
22 May 2023

Article published online:
19 June 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Liang H, Acharya G. Novel corona virus disease (COVID-19) in pregnancy: what clinical recommendations to follow?. Acta Obstet Gynecol Scand 2020; 99 (04) 439-442
  • 2 Thompson JL, Nguyen LM, Noble KN, Aronoff DM. COVID-19-related disease severity in pregnancy. Am J Reprod Immunol 2020; 84 (05) e13339
  • 3 Yang H, Wang C, Poon LC. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol 2020; 55 (04) 435-437
  • 4 Wong MJ, Bharadwaj S, Lankford AS, Galey JL, Kodali BS. Mechanical ventilation and prone positioning in pregnant patients with severe COVID-19 pneumonia: experience at a quaternary referral center. Int J Obstet Anesth 2022; 49: 103236
  • 5 Ouyang L, Yu M, Zhu Y, Gong J. Respiratory supports of COVID-19 patients in intensive care unit: a systematic review. Heliyon 2021; 7 (04) e06813
  • 6 Agerstrand C, Abrams D, Biscotti M. et al. Extracorporeal membrane oxygenation for cardiopulmonary failure during pregnancy and postpartum. Ann Thorac Surg 2016; 102 (03) 774-779
  • 7 Yamamoto L, Santos EHD, Pinto LS. et al. SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review. Rev Inst Med Trop São Paulo 2020; 62: e65
  • 8 Tambawala ZY, Hakim ZT, Hamza LK, Al Rayes M. Successful management of severe acute respiratory distress syndrome due to COVID-19 with extracorporeal membrane oxygenation during mid-trimester of pregnancy. BMJ Case Rep 2021; 14 (02) e240823
  • 9 Péju E, Belicard F, Silva S. et al; COVIDPREG Study Group. Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection: the multicenter and international COVIDPREG study. Intensive Care Med 2022; 48 (09) 1185-1196
  • 10 Fiore A, Piscitelli M, Adodo DK. et al. Successful use of extracorPoreal membrane oxygenation postpartum as rescue therapy in a woman with COVID-19. J Cardiothorac Vasc Anesth 2021; 35 (07) 2140-2143
  • 11 Ntounis T, Prokopakis I, Koutras A. et al. Pregnancy and COVID-19. J Clin Med 2022; 11 (22) 6645
  • 12 Vasquez Muñoz N et. Características clínicas de las Pacientes embarazadas de infección confirmada por SARS-CoV-2 y desenlaces adversos maternos en Colombia. Paper presented at: XXIII Congr Latinoam Obs y Ginecol Paraguay; April 25–26, 2021
  • 13 Barrantes JH, Ortoleva J, O'Neil ER. et al. Successful treatment of pregnant and postpartum women with severe COVID-19 associated acute respiratory distress syndrome with extracorporeal membrane oxygenation. ASAIO J 2021; 67 (02) 132-136
  • 14 O'Neil ER, Lin H, Shamshirsaz AA. et al. Pregnant and peripartum women with COVID-19 have high survival with extracorporeal membrane oxygenation: an Extracorporeal Life Support Organization Registry Analysis. Am J Respir Crit Care Med 2022; 205 (02) 248-250
  • 15 Ong J, Zhang JJY, Lorusso R, MacLaren G, Ramanathan K. Extracorporeal membrane oxygenation in pregnancy and the postpartum period: a systematic review of case reports. Int J Obstet Anesth 2020; 43: 106-113
  • 16 Knight M, Bunch K, Vousden N. et al; UK Obstetric Surveillance System SARS-CoV-2 Infection in Pregnancy Collaborative Group. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020; 369: m2107
  • 17 Larson SB, Watson SN, Eberlein M. et al. Survival of pregnant coronavirus patient on extracorporeal membrane oxygenation. Ann Thorac Surg 2021; 111: 151-152
  • 18 Salazar L, Bermon A, Vasquez R. et al. Improving extracorporeal membrane oxygenation survival in COVID-19. Effect of a bundle of care. ASAIO J 2022; 68 (10) 1233-1240
  • 19 Sato R, Dugar S, Cheungpasitporn W. et al. The impact of right ventricular injury on the mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 2021; 25 (01) 172
  • 20 Paternoster G, Bertini P, Innelli P. et al. Right ventricular dysfunction in patients with COVID-19: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 2021; 35 (11) 3319-3324
  • 21 Cain MT, Smith NJ, Barash M. et al. Extracorporeal membrane oxygenation with right ventricular assist device for COVID-19 ARDS. J Surg Res 2021; 264: 81-89
  • 22 Shih E, DiMaio JM, Squiers JJ. et al. Treatment of acute respiratory distress syndrome from COVID-19 with extracorporeal membrane oxygenation in obstetrical patients. Am J Obstet Gynecol MFM 2022; 4 (02) 100537
  • 23 Pacheco LD, Saade GR, Hankins GDV. Extracorporeal membrane oxygenation (ECMO) during pregnancy and postpartum. Semin Perinatol 2018; 42 (01) 21-25
  • 24 Varvoutis M, Wein LE, Sugrue R. et al. Pregnancy-associated Extracorporeal membrane oxygenation in the United States. Am J Perinatol 2023; (e-pub ahead of print). DOI: 10.1055/a-2008-8462.
  • 25 Wang H, Li N, Sun C. et al. The association between pregnancy and COVID-19: a systematic review and meta-analysis. Am J Emerg Med 2022; 56: 188-195
  • 26 Chopra S, Syal A, Arya Y. Acute kidney injury in COVID-19: considerations in pregnancy. Tzu-Chi Med J 2021; 34 (01) 29-34
  • 27 Lamouroux A, Attie-Bitach T, Martinovic J, Leruez-Ville M, Ville Y. Evidence for and against vertical transmission for severe acute respiratory syndrome coronavirus 2. Am J Obstet Gynecol 2020; 223 (01) 91.e1-91.e4
  • 28 Salazar L, Arora L, Botia M. et al. Somatic support with veno-venous ECMO in a pregnant woman with brain death. ASAIO J 2022; 68 (01) e16-e18
  • 29 Sukhikh G, Petrova U, Prikhodko A. et al. Vertical transmission of SARS-CoV-2 in second trimester associated with severe neonatal pathology. Viruses 2021; 13 (03) 1-11
  • 30 Durán-Strauch E. Momento difícil para la salud y el bienestar de la niñez [in Spanish]. Biomédica 2021; 41 (03) 384-387
  • 31 Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol 2022; 226 (02) 177-186